China Medical GatewayLoading your healthcare gateway…

Sun Yat-sen University Cancer Center (SYSUCC)

Sun Yat-sen University Cancer Center (SYSUCC) — Guangzhou

Hospital Profile

The Sun Yat-sen University Cancer Prevention and Treatment Center (Sun Yat-sen University Affiliated Cancer Hospital, Sun Yat-sen University Cancer Research Institute) was established in March 1964 and is one of the four earliest cancer hospitals founded in the People's Republic of China. It is one of the largest and academically strongest oncology bases in the country, integrating medical treatment, teaching, research, and prevention. The center undertakes the national responsibility for cancer prevention and treatment and plays a leading role in cancer prevention and treatment nationwide, especially in South China and the Hong Kong, Macao, and Taiwan regions. Its disciplinary status and comprehensive strength are at the national leading level. The center currently hosts the National Key Discipline (Oncology), the National Key Laboratory for the Prevention and Treatment of Malignant Tumors in South China, the Ministry of Education Key Laboratory, the National New Drug (Anti-Cancer Drug) Clinical Trial Research Center, and the Provincial-Ministry Collaborative Innovation Center of Oncology Medicine. It also serves as the supporting institution for the Guangdong Cancer Center and the Guangdong Esophageal Cancer Research Institute. It publishes the English academic journal Cancer Communications, with an impact factor of 24.9 (JCR 2024), ranking in Q1 in the JCR Oncology category and first overall among comprehensive academic journals in the field of oncology. Its scientific and technological influence ranks first in the "2023 China Hospital Science and Technology Value Rankings (Oncology)", and in the 2024 Nature Index rankings, it ranks fifth globally among cancer centers. The center has been repeatedly recognized as one of China’s Best Employers among medical institutions. It is actively promoting the construction of the Tianhe Campus and looks forward to building it into a world-class cancer center with Chinese characteristics.

Medical Milestones

Founded in March 1964. In 1998, it took the lead in implementing the Chief Expert Responsibility System for Single Tumor Types nationwide. Since 1964, the Ministry of Health has entrusted it to run the National Oncology Clinical Medicine Advanced Training Program, having trained more than 5,000 oncology professionals across the country. Since 1990, it has been exploring standardized residency training for oncology hospitals; in September 2014, it was approved as one of the first national standardized residency training bases and now has 10 national-level standardized residency training specialty bases. The journal it sponsors was indexed by SCI in 2014. In the past five years, more than 92 frontline clinical research achievements have been internationally recognized and adopted into global tumor diagnosis and treatment standards and guidelines. In recent years, as the primary unit of completion, it has won a total of 76 provincial and ministerial-level or higher scientific research achievement awards (including 2 second-class National Natural Science Awards and 6 second-class National Science and Technology Progress Awards, among others). It has established a sister hospital relationship with the M.D. Anderson Cancer Center, and the hospital has been awarded the "International Science and Technology Cooperation Award of the People's Republic of China."

Key Capabilities & Patient Care

With leading medical technology, it has a radiotherapy center with first-class hardware and software conditions in Asia, carrying out multiple specialized minimally invasive surgeries with surgical robots; it organizes the formulation of multidisciplinary comprehensive treatment plans for major diseases, providing individualized and highest-quality medical services for a wide range of cancer patients. It is one of the domestic cradle for training high-level oncology talents, and serves as the chief editor for national-level oncology planning textbooks 'Clinical Oncology' and 'Oncology'. By optimizing the management system and advancing hardware and software construction, it has built a garden-style humanistic hospital that is convenient for patients, with reasonable procedures and a welcoming atmosphere; inheriting the cultural values of 'honesty, friendship, dedication, and innovation,' it has formed a happy, united, and progressive culture of working with a sense of belonging to the hospital.

Advanced Technology

There are currently 334 master's supervisors and 231 doctoral supervisors; 3 academicians of the Chinese Academy of Sciences, 3 academicians of the Chinese Academy of Engineering, and 47 national-level talents. There are two campuses, Yuexiu and Huangpu, and construction of the Tianhe campus is underway. It has an Asia-first-class radiotherapy center and minimally invasive surgical equipment with surgical robots, both in terms of hardware and software. • Bed capacity: 2,245 actual open beds (2026; Yuexiu campus 1,571 beds, Huangpu campus 674 beds) • Total staff: not publicly disclosed, estimated 3,500–4,500 people • Inpatients: annual hospitalization reaches 222,000 cases (2026) • Outpatient and emergency visits: 2.558 million visits (2026) • Inpatient and elective surgeries: nearly 50,000 surgical operations annually (2025) • Number of senior title physicians: official total not disclosed; estimated around 480–640 people (this is an estimate, not official data, calculated based on 4,000 staff × 12%-16%)

International Patient Services

Establish a high-level international partnership network, form a sister hospital relationship with the University of Texas M.D. Anderson Cancer Center, which is ranked number one in oncology in the United States, and establish close connections with world-leading institutions such as Sweden's Karolinska Institute, the University of Warwick in the UK, the Royal College of Surgeons of Australia, and the Erasmus Medical Center in the Netherlands, jointly carrying out multiple international cooperation projects. We look forward to providing high-quality, humane medical services to cancer patients both domestically and internationally with first-class equipment, superb technology, elegant environment, and scientific processes.

Return to Home